Clinical Trials Browser

Combined Pituitary Hormone Deficiency, Congenital Abnormalities, Acromegaly, Gigantism, Prolactinoma, Pituitary ACTH Hypersecretion, Carcinogenesis

NCT07306325 2025-12-29

Ultrasound in Predicting Difficult Intubation in Acromegaly Patients

Not yet recruiting

34 enrolled

Endocrine

Acromegaly, Growth Hormone-Secreting Pituitary Adenoma

NCT07179926 2025-09-18

Pasi-Bone

Recruiting

120 enrolled

Endocrine

Acromegaly, Growth Hormone-Secreting Pituitary Adenoma

NCT01809808 2025-08-26

A Prospective Study of Outcome After Therapy for Acromegaly

Completed

280 enrolled

Endocrine

Acromegaly, Pituitary Neoplasms

NCT06253897 2024-12-24

BackSOM

Completed

20 enrolled

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Acromegaly

NCT01794793 2024-10-01

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Phase 4 Completed

337 enrolled 8 charts

DermatologicEndocrineGenitourinaryNET

Acromegaly, Dumping Syndrome, Melanoma, Neoplasms, Pituitary Neoplasms, Prostatic Neoplasms, Neuroendocrine Tumors, Pituitary ACTH Hypersecretion

NCT06326853 2024-06-11

Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models

Not yet recruiting

200 enrolled

EndocrineOther

Acromegaly, Cushing Syndrome, Endocrine System Diseases, Hypopituitarism, Obesity, Pituitary Neoplasms

NCT02419664 2022-03-31

Ga-68-DOTATOC -PET in the Management of Pituitary Tumours

Phase 3 Terminated

22 enrolled

Endocrine

Acromegaly, Pituitary Diseases, Pituitary Neoplasms

NCT01861717 2021-09-30

A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.

Phase 4 Terminated

4 enrolled 5 charts

Endocrine

Acromegaly, Gigantism, Pituitary Neoplasms

NCT00001981 2020-11-27

The Treatment and Natural History of Acromegaly

Completed

117 enrolled

Endocrine

Acromegaly, Pituitary Neoplasms

NCT04529356 2020-08-27

The TMS Treatment for Postoperative Headache in GH Tumor

Phase NA Unknown

200 enrolled

Endocrine

Acromegaly, Headache, Pituitary Neoplasms

NCT01673646 2019-09-16

Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism

Phase 2 Completed

33 enrolled 24 charts

Endocrine

Acromegaly, Gigantism, Growth Disorders, Pituitary Neoplasms

NCT01840449 2019-01-14

SOPRANo

Completed

156 enrolled

EndocrineNET

Acromegaly, Neuroendocrine Tumors

NCT01504399 2018-08-22

Rhinological Outcomes in Endonasal Pituitary Surgery

Completed

235 enrolled

Endocrine

Acromegaly, Adrenocortical Hyperfunction, Pituitary Neoplasms, Prolactinoma

NCT03439709 2018-03-01

MERGE

Phase 3 Unknown

90 enrolled

Endocrine

Acromegaly, Pituitary Neoplasms, Growth Hormone-Secreting Pituitary Adenoma

NCT02299089 2017-12-15

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Phase 2 Completed

12 enrolled 18 charts

EndocrineNET

Acromegaly, Neuroendocrine Tumors, Serotonin Syndrome

NCT00376064 2017-03-06

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Phase 4 Completed

20 enrolled

CNSEndocrine

Acromegaly, Brain Neoplasms, Pituitary Neoplasms

NCT02854228 2016-08-03

PITUICARE-Lyon

Unknown

1,300 enrolled

Endocrine

Acromegaly, Pituitary Neoplasms, Prolactinoma

NCT01368133 2013-09-26

The Observational Study of Growth Hormone-secreting Pituitary Tumors

Unknown

60 enrolled

Endocrine

Acromegaly, Pituitary Neoplasms

NCT00598949 2010-12-15

Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma

Unknown

600 enrolled

Endocrine

Acromegaly, Adenoma, Neoplasms, Pituitary Diseases, Pituitary Neoplasms, Prolactinoma

NCT00001860 2008-03-04

Sandostatin LAR Depot vs. Surgery for Treating Acromegaly

Phase 2 Completed

5 enrolled

Endocrine

Acromegaly, Pituitary Neoplasms

NCT00461149 2007-04-17

HDacro

Phase 4 Completed

50 enrolled

Endocrine

Acromegaly, Pituitary Neoplasms

Clinical Trials

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

Ultrasound in Predicting Difficult Intubation in Acromegaly Patients

Pasi-Bone

A Prospective Study of Outcome After Therapy for Acromegaly

BackSOM

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models

Ga-68-DOTATOC -PET in the Management of Pituitary Tumours

A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.

The Treatment and Natural History of Acromegaly

The TMS Treatment for Postoperative Headache in GH Tumor

Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism

SOPRANo

Rhinological Outcomes in Endonasal Pituitary Surgery

MERGE

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

PITUICARE-Lyon

The Observational Study of Growth Hormone-secreting Pituitary Tumors

Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma

Sandostatin LAR Depot vs. Surgery for Treating Acromegaly

HDacro